Patients with Advanced Cancer May Benefit from Discussing Prognosis with Physicians

Patients with advanced cancer may benefit from having discussions about their prognoses with their physicians. Source link

A Holistic Approach to Cancer Health Disparities

Recognizing that complex factors underlie health disparities, NCI is taking a holistic approach in our efforts to address this serious...

FDA Approves Nivolumab for Some Melanomas and Lung Cancers

The FDA has approved nivolumab in combination with ipilimumab for advanced melanoma and nivolumab alone for advanced nonsquamous lung cancer....

Antioxidants Accelerate the Growth and Invasiveness of Tumors in Mice

Metastatic tumor cells are particularly sensitive to oxidative stress, and antioxidant supplementation increases their ability to grow and metastasize. Source...

Bringing Precision to Screening for Cancer

A recent NCI-sponsored conference brought together leading screening and cancer control researchers to discuss the state of the science of...

FDA Approves Pembrolizumab for Patients with Non-Small Cell Lung Cancer

The FDA has approved the drug pembrolizumab to treat patients with advanced non-small cell lung cancer (NSCLC) whose tumors express...

How Genomics Is Shaping Precision Medicine in Oncology

In laboratories at NCI and around the world, researchers are using advanced genomic technologies to study the differences between cancer...

What Is a Colonoscopy and Why Do I Need It?

Screening for colorectal cancer is important for your health. There’s a recommendation that people over 50, particularly those with colon...

FDA Grants Brigatinib Accelerated Approval for Metastatic Non-Small Cell Lung Cancer

On April 28, the FDA granted accelerated approval to the targeted therapy brigatinib (Alunbrig™) for patients with metastatic non-small cell...